nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMP—endothelium—malignant glioma	0.00984	0.178	CbGeAlD
Capecitabine—TYMP—blood vessel—malignant glioma	0.00908	0.164	CbGeAlD
Capecitabine—Skin hyperpigmentation—Carmustine—malignant glioma	0.00648	0.00881	CcSEcCtD
Capecitabine—Febrile neutropenia—Carmustine—malignant glioma	0.0064	0.00871	CcSEcCtD
Capecitabine—Haemorrhoids—Temozolomide—malignant glioma	0.00633	0.00861	CcSEcCtD
Capecitabine—Visual acuity reduced—Temozolomide—malignant glioma	0.00626	0.00851	CcSEcCtD
Capecitabine—Febrile neutropenia—Temozolomide—malignant glioma	0.00619	0.00842	CcSEcCtD
Capecitabine—Deep vein thrombosis—Temozolomide—malignant glioma	0.00612	0.00832	CcSEcCtD
Capecitabine—Oral candidiasis—Carmustine—malignant glioma	0.00606	0.00825	CcSEcCtD
Capecitabine—Encephalopathy—Carmustine—malignant glioma	0.006	0.00816	CcSEcCtD
Capecitabine—Aphasia—Carmustine—malignant glioma	0.00594	0.00808	CcSEcCtD
Capecitabine—Oral candidiasis—Temozolomide—malignant glioma	0.00586	0.00797	CcSEcCtD
Capecitabine—Embolism—Temozolomide—malignant glioma	0.0058	0.00789	CcSEcCtD
Capecitabine—Aphasia—Temozolomide—malignant glioma	0.00574	0.00781	CcSEcCtD
Capecitabine—Thrombosis—Carmustine—malignant glioma	0.00544	0.0074	CcSEcCtD
Capecitabine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00503	0.00684	CcSEcCtD
Capecitabine—Hepatotoxicity—Carmustine—malignant glioma	0.00499	0.00678	CcSEcCtD
Capecitabine—Herpes zoster—Temozolomide—malignant glioma	0.00494	0.00672	CcSEcCtD
Capecitabine—Hepatotoxicity—Temozolomide—malignant glioma	0.00482	0.00656	CcSEcCtD
Capecitabine—Coagulopathy—Temozolomide—malignant glioma	0.00478	0.0065	CcSEcCtD
Capecitabine—Otitis media—Temozolomide—malignant glioma	0.00478	0.0065	CcSEcCtD
Capecitabine—Hyperaesthesia—Temozolomide—malignant glioma	0.00474	0.00645	CcSEcCtD
Capecitabine—Memory impairment—Temozolomide—malignant glioma	0.00474	0.00645	CcSEcCtD
Capecitabine—Injection site pain—Carmustine—malignant glioma	0.00472	0.00642	CcSEcCtD
Capecitabine—Rigors—Temozolomide—malignant glioma	0.00456	0.0062	CcSEcCtD
Capecitabine—Petechiae—Temozolomide—malignant glioma	0.00452	0.00615	CcSEcCtD
Capecitabine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00409	0.00557	CcSEcCtD
Capecitabine—Herpes simplex—Temozolomide—malignant glioma	0.00404	0.00549	CcSEcCtD
Capecitabine—Gait disturbance—Carmustine—malignant glioma	0.00395	0.00537	CcSEcCtD
Capecitabine—Coordination abnormal—Carmustine—malignant glioma	0.00392	0.00533	CcSEcCtD
Capecitabine—Hearing impaired—Temozolomide—malignant glioma	0.00391	0.00532	CcSEcCtD
Capecitabine—Neck pain—Carmustine—malignant glioma	0.0039	0.0053	CcSEcCtD
Capecitabine—Pulmonary embolism—Carmustine—malignant glioma	0.00385	0.00524	CcSEcCtD
Capecitabine—Injection site reaction—Carmustine—malignant glioma	0.00383	0.00521	CcSEcCtD
Capecitabine—Gait disturbance—Temozolomide—malignant glioma	0.00381	0.00519	CcSEcCtD
Capecitabine—Coordination abnormal—Temozolomide—malignant glioma	0.00379	0.00516	CcSEcCtD
Capecitabine—TYMS—telencephalon—malignant glioma	0.00378	0.0683	CbGeAlD
Capecitabine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00372	0.00506	CcSEcCtD
Capecitabine—Pulmonary embolism—Temozolomide—malignant glioma	0.00372	0.00506	CcSEcCtD
Capecitabine—Depressed level of consciousness—Carmustine—malignant glioma	0.00372	0.00506	CcSEcCtD
Capecitabine—Urinary incontinence—Carmustine—malignant glioma	0.00372	0.00506	CcSEcCtD
Capecitabine—Skin exfoliation—Carmustine—malignant glioma	0.00368	0.005	CcSEcCtD
Capecitabine—Candida infection—Carmustine—malignant glioma	0.00368	0.005	CcSEcCtD
Capecitabine—Neuropathy—Carmustine—malignant glioma	0.00362	0.00492	CcSEcCtD
Capecitabine—Influenza like illness—Temozolomide—malignant glioma	0.00361	0.00492	CcSEcCtD
Capecitabine—Urinary incontinence—Temozolomide—malignant glioma	0.00359	0.00489	CcSEcCtD
Capecitabine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00359	0.00489	CcSEcCtD
Capecitabine—Skin exfoliation—Temozolomide—malignant glioma	0.00355	0.00483	CcSEcCtD
Capecitabine—Candida infection—Temozolomide—malignant glioma	0.00355	0.00483	CcSEcCtD
Capecitabine—Neuropathy—Temozolomide—malignant glioma	0.00349	0.00475	CcSEcCtD
Capecitabine—Neoplasm—Carmustine—malignant glioma	0.00348	0.00474	CcSEcCtD
Capecitabine—TYMP—medulla oblongata—malignant glioma	0.00346	0.0626	CbGeAlD
Capecitabine—Dry eye—Temozolomide—malignant glioma	0.00344	0.00468	CcSEcCtD
Capecitabine—DPYD—brain—malignant glioma	0.00343	0.062	CbGeAlD
Capecitabine—Neoplasm—Temozolomide—malignant glioma	0.00337	0.00458	CcSEcCtD
Capecitabine—Abnormal vision—Carmustine—malignant glioma	0.00336	0.00457	CcSEcCtD
Capecitabine—Sepsis—Carmustine—malignant glioma	0.00334	0.00455	CcSEcCtD
Capecitabine—Mental disability—Carmustine—malignant glioma	0.00334	0.00455	CcSEcCtD
Capecitabine—Abnormal vision—Temozolomide—malignant glioma	0.00325	0.00442	CcSEcCtD
Capecitabine—Phlebitis—Carmustine—malignant glioma	0.00325	0.00441	CcSEcCtD
Capecitabine—Mental disability—Temozolomide—malignant glioma	0.00323	0.00439	CcSEcCtD
Capecitabine—Thrombophlebitis—Carmustine—malignant glioma	0.00323	0.00439	CcSEcCtD
Capecitabine—Diabetes mellitus—Carmustine—malignant glioma	0.00321	0.00437	CcSEcCtD
Capecitabine—Swelling—Carmustine—malignant glioma	0.00317	0.00431	CcSEcCtD
Capecitabine—Ear pain—Temozolomide—malignant glioma	0.00317	0.00431	CcSEcCtD
Capecitabine—TYMP—midbrain—malignant glioma	0.00316	0.0572	CbGeAlD
Capecitabine—Thrombophlebitis—Temozolomide—malignant glioma	0.00312	0.00425	CcSEcCtD
Capecitabine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00311	0.00423	CcSEcCtD
Capecitabine—Eye pain—Carmustine—malignant glioma	0.0031	0.00421	CcSEcCtD
Capecitabine—TYMP—spinal cord—malignant glioma	0.00309	0.0558	CbGeAlD
Capecitabine—Gastroenteritis—Temozolomide—malignant glioma	0.00305	0.00415	CcSEcCtD
Capecitabine—Vascular purpura—Temozolomide—malignant glioma	0.00302	0.00411	CcSEcCtD
Capecitabine—Deafness—Temozolomide—malignant glioma	0.00302	0.00411	CcSEcCtD
Capecitabine—Hepatic failure—Temozolomide—malignant glioma	0.00301	0.00409	CcSEcCtD
Capecitabine—Eye pain—Temozolomide—malignant glioma	0.00299	0.00407	CcSEcCtD
Capecitabine—Amnesia—Carmustine—malignant glioma	0.00298	0.00405	CcSEcCtD
Capecitabine—Hot flush—Temozolomide—malignant glioma	0.00289	0.00393	CcSEcCtD
Capecitabine—Amnesia—Temozolomide—malignant glioma	0.00288	0.00391	CcSEcCtD
Capecitabine—Menopausal symptoms—Temozolomide—malignant glioma	0.00286	0.00389	CcSEcCtD
Capecitabine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00286	0.00389	CcSEcCtD
Capecitabine—Thirst—Temozolomide—malignant glioma	0.00284	0.00386	CcSEcCtD
Capecitabine—Hyponatraemia—Carmustine—malignant glioma	0.00281	0.00382	CcSEcCtD
Capecitabine—Purpura—Temozolomide—malignant glioma	0.0028	0.00381	CcSEcCtD
Capecitabine—Diplopia—Carmustine—malignant glioma	0.0028	0.0038	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0028	0.0038	CcSEcCtD
Capecitabine—TYMP—Nucleotide metabolism—CAT—malignant glioma	0.00272	0.013	CbGpPWpGaD
Capecitabine—TYMS—midbrain—malignant glioma	0.00271	0.0491	CbGeAlD
Capecitabine—Diplopia—Temozolomide—malignant glioma	0.0027	0.00368	CcSEcCtD
Capecitabine—Face oedema—Carmustine—malignant glioma	0.0027	0.00367	CcSEcCtD
Capecitabine—Ataxia—Carmustine—malignant glioma	0.00263	0.00358	CcSEcCtD
Capecitabine—Face oedema—Temozolomide—malignant glioma	0.00261	0.00355	CcSEcCtD
Capecitabine—Liver function test abnormal—Carmustine—malignant glioma	0.00258	0.00351	CcSEcCtD
Capecitabine—Mood swings—Temozolomide—malignant glioma	0.00256	0.00348	CcSEcCtD
Capecitabine—Hypokalaemia—Carmustine—malignant glioma	0.00254	0.00346	CcSEcCtD
Capecitabine—Ataxia—Temozolomide—malignant glioma	0.00254	0.00346	CcSEcCtD
Capecitabine—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00252	0.012	CbGpPWpGaD
Capecitabine—Dehydration—Temozolomide—malignant glioma	0.00251	0.00342	CcSEcCtD
Capecitabine—TYMP—central nervous system—malignant glioma	0.0025	0.0453	CbGeAlD
Capecitabine—Dry skin—Temozolomide—malignant glioma	0.00248	0.00337	CcSEcCtD
Capecitabine—Muscular weakness—Carmustine—malignant glioma	0.00247	0.00335	CcSEcCtD
Capecitabine—Hypokalaemia—Temozolomide—malignant glioma	0.00246	0.00334	CcSEcCtD
Capecitabine—TYMP—cerebellum—malignant glioma	0.00245	0.0442	CbGeAlD
Capecitabine—Breast disorder—Temozolomide—malignant glioma	0.00244	0.00332	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00243	0.00331	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00243	0.00331	CcSEcCtD
Capecitabine—Dysphagia—Carmustine—malignant glioma	0.00242	0.00329	CcSEcCtD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—malignant glioma	0.0024	0.0115	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—malignant glioma	0.00238	0.0114	CbGpPWpGaD
Capecitabine—Muscular weakness—Temozolomide—malignant glioma	0.00238	0.00324	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00238	0.00324	CcSEcCtD
Capecitabine—Abdominal distension—Temozolomide—malignant glioma	0.00235	0.0032	CcSEcCtD
Capecitabine—Dysphagia—Temozolomide—malignant glioma	0.00234	0.00318	CcSEcCtD
Capecitabine—Pancytopenia—Carmustine—malignant glioma	0.00229	0.00312	CcSEcCtD
Capecitabine—Sweating increased—Temozolomide—malignant glioma	0.00227	0.00309	CcSEcCtD
Capecitabine—Neutropenia—Carmustine—malignant glioma	0.00226	0.00307	CcSEcCtD
Capecitabine—Bronchitis—Temozolomide—malignant glioma	0.00225	0.00305	CcSEcCtD
Capecitabine—Pancytopenia—Temozolomide—malignant glioma	0.00222	0.00302	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—MYC—malignant glioma	0.00219	0.0105	CbGpPWpGaD
Capecitabine—Dysuria—Temozolomide—malignant glioma	0.00218	0.00297	CcSEcCtD
Capecitabine—Neutropenia—Temozolomide—malignant glioma	0.00218	0.00297	CcSEcCtD
Capecitabine—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00218	0.0104	CbGpPWpGaD
Capecitabine—Hyperglycaemia—Carmustine—malignant glioma	0.00218	0.00296	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00217	0.00295	CcSEcCtD
Capecitabine—Pneumonia—Carmustine—malignant glioma	0.00217	0.00295	CcSEcCtD
Capecitabine—CES1—central nervous system—malignant glioma	0.00216	0.0391	CbGeAlD
Capecitabine—Depression—Carmustine—malignant glioma	0.00215	0.00292	CcSEcCtD
Capecitabine—TYMS—central nervous system—malignant glioma	0.00215	0.0388	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—EGFR—malignant glioma	0.00215	0.0102	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—malignant glioma	0.00214	0.0102	CbGpPWpGaD
Capecitabine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00213	0.0029	CcSEcCtD
Capecitabine—Weight increased—Temozolomide—malignant glioma	0.00213	0.00289	CcSEcCtD
Capecitabine—Renal failure—Carmustine—malignant glioma	0.00212	0.00288	CcSEcCtD
Capecitabine—Weight decreased—Temozolomide—malignant glioma	0.00211	0.00287	CcSEcCtD
Capecitabine—Neuropathy peripheral—Carmustine—malignant glioma	0.00211	0.00287	CcSEcCtD
Capecitabine—Hyperglycaemia—Temozolomide—malignant glioma	0.00211	0.00287	CcSEcCtD
Capecitabine—DPYD—Metabolism—RTEL1—malignant glioma	0.00211	0.01	CbGpPWpGaD
Capecitabine—Stomatitis—Carmustine—malignant glioma	0.0021	0.00286	CcSEcCtD
Capecitabine—TYMS—cerebellum—malignant glioma	0.0021	0.0379	CbGeAlD
Capecitabine—Urinary tract infection—Carmustine—malignant glioma	0.00209	0.00285	CcSEcCtD
Capecitabine—Pneumonia—Temozolomide—malignant glioma	0.00209	0.00285	CcSEcCtD
Capecitabine—Infestation NOS—Temozolomide—malignant glioma	0.00208	0.00283	CcSEcCtD
Capecitabine—Infestation—Temozolomide—malignant glioma	0.00208	0.00283	CcSEcCtD
Capecitabine—Depression—Temozolomide—malignant glioma	0.00208	0.00282	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00206	0.00281	CcSEcCtD
Capecitabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00204	0.00278	CcSEcCtD
Capecitabine—Stomatitis—Temozolomide—malignant glioma	0.00203	0.00276	CcSEcCtD
Capecitabine—Urinary tract infection—Temozolomide—malignant glioma	0.00202	0.00275	CcSEcCtD
Capecitabine—TYMP—brain—malignant glioma	0.00199	0.0359	CbGeAlD
Capecitabine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00197	0.00268	CcSEcCtD
Capecitabine—Haemoglobin—Carmustine—malignant glioma	0.00194	0.00264	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—NTRK3—malignant glioma	0.00193	0.00923	CbGpPWpGaD
Capecitabine—Haemorrhage—Carmustine—malignant glioma	0.00193	0.00263	CcSEcCtD
Capecitabine—Hypoaesthesia—Carmustine—malignant glioma	0.00192	0.00262	CcSEcCtD
Capecitabine—Oedema peripheral—Carmustine—malignant glioma	0.00191	0.00259	CcSEcCtD
Capecitabine—Connective tissue disorder—Carmustine—malignant glioma	0.0019	0.00259	CcSEcCtD
Capecitabine—Haemoglobin—Temozolomide—malignant glioma	0.00188	0.00256	CcSEcCtD
Capecitabine—CDA—Metabolism—RTEL1—malignant glioma	0.00188	0.00895	CbGpPWpGaD
Capecitabine—Hepatitis—Temozolomide—malignant glioma	0.00187	0.00254	CcSEcCtD
Capecitabine—Haemorrhage—Temozolomide—malignant glioma	0.00187	0.00254	CcSEcCtD
Capecitabine—Visual impairment—Carmustine—malignant glioma	0.00186	0.00254	CcSEcCtD
Capecitabine—Hypoaesthesia—Temozolomide—malignant glioma	0.00186	0.00253	CcSEcCtD
Capecitabine—Pharyngitis—Temozolomide—malignant glioma	0.00186	0.00252	CcSEcCtD
Capecitabine—Urinary tract disorder—Temozolomide—malignant glioma	0.00185	0.00251	CcSEcCtD
Capecitabine—Oedema peripheral—Temozolomide—malignant glioma	0.00184	0.0025	CcSEcCtD
Capecitabine—Connective tissue disorder—Temozolomide—malignant glioma	0.00184	0.0025	CcSEcCtD
Capecitabine—Urethral disorder—Temozolomide—malignant glioma	0.00183	0.00249	CcSEcCtD
Capecitabine—Eye disorder—Carmustine—malignant glioma	0.00181	0.00246	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—TP53—malignant glioma	0.0018	0.0086	CbGpPWpGaD
Capecitabine—Visual impairment—Temozolomide—malignant glioma	0.0018	0.00245	CcSEcCtD
Capecitabine—Flushing—Carmustine—malignant glioma	0.0018	0.00244	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.00177	0.00845	CbGpPWpGaD
Capecitabine—Erythema multiforme—Temozolomide—malignant glioma	0.00177	0.0024	CcSEcCtD
Capecitabine—Eye disorder—Temozolomide—malignant glioma	0.00175	0.00238	CcSEcCtD
Capecitabine—Tinnitus—Temozolomide—malignant glioma	0.00174	0.00237	CcSEcCtD
Capecitabine—Flushing—Temozolomide—malignant glioma	0.00173	0.00236	CcSEcCtD
Capecitabine—Cardiac disorder—Temozolomide—malignant glioma	0.00173	0.00236	CcSEcCtD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00173	0.00825	CbGpPWpGaD
Capecitabine—Arrhythmia—Carmustine—malignant glioma	0.00173	0.00235	CcSEcCtD
Capecitabine—CES1—brain—malignant glioma	0.00172	0.031	CbGeAlD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—malignant glioma	0.00171	0.00818	CbGpPWpGaD
Capecitabine—Alopecia—Carmustine—malignant glioma	0.00171	0.00232	CcSEcCtD
Capecitabine—TYMS—brain—malignant glioma	0.00171	0.0308	CbGeAlD
Capecitabine—Angiopathy—Temozolomide—malignant glioma	0.0017	0.00231	CcSEcCtD
Capecitabine—Mental disorder—Carmustine—malignant glioma	0.00169	0.0023	CcSEcCtD
Capecitabine—Immune system disorder—Temozolomide—malignant glioma	0.00169	0.0023	CcSEcCtD
Capecitabine—Mediastinal disorder—Temozolomide—malignant glioma	0.00168	0.00229	CcSEcCtD
Capecitabine—Malnutrition—Carmustine—malignant glioma	0.00168	0.00229	CcSEcCtD
Capecitabine—Erythema—Carmustine—malignant glioma	0.00168	0.00229	CcSEcCtD
Capecitabine—Chills—Temozolomide—malignant glioma	0.00168	0.00228	CcSEcCtD
Capecitabine—Alopecia—Temozolomide—malignant glioma	0.00165	0.00225	CcSEcCtD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00165	0.00786	CbGpPWpGaD
Capecitabine—Mental disorder—Temozolomide—malignant glioma	0.00164	0.00223	CcSEcCtD
Capecitabine—Back pain—Carmustine—malignant glioma	0.00163	0.00222	CcSEcCtD
Capecitabine—Malnutrition—Temozolomide—malignant glioma	0.00163	0.00221	CcSEcCtD
Capecitabine—Erythema—Temozolomide—malignant glioma	0.00163	0.00221	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00161	0.00769	CbGpPWpGaD
Capecitabine—Dysgeusia—Temozolomide—malignant glioma	0.00159	0.00217	CcSEcCtD
Capecitabine—Vision blurred—Carmustine—malignant glioma	0.00159	0.00216	CcSEcCtD
Capecitabine—Tremor—Carmustine—malignant glioma	0.00158	0.00215	CcSEcCtD
Capecitabine—Back pain—Temozolomide—malignant glioma	0.00157	0.00214	CcSEcCtD
Capecitabine—Anaemia—Carmustine—malignant glioma	0.00156	0.00212	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—SLC5A5—malignant glioma	0.00155	0.00739	CbGpPWpGaD
Capecitabine—Vision blurred—Temozolomide—malignant glioma	0.00153	0.00209	CcSEcCtD
Capecitabine—Tremor—Temozolomide—malignant glioma	0.00152	0.00207	CcSEcCtD
Capecitabine—Ill-defined disorder—Temozolomide—malignant glioma	0.00151	0.00205	CcSEcCtD
Capecitabine—Leukopenia—Carmustine—malignant glioma	0.00151	0.00205	CcSEcCtD
Capecitabine—Anaemia—Temozolomide—malignant glioma	0.0015	0.00205	CcSEcCtD
Capecitabine—TYMP—Metabolism—RTEL1—malignant glioma	0.0015	0.00716	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC6A3—malignant glioma	0.00147	0.00703	CbGpPWpGaD
Capecitabine—Malaise—Temozolomide—malignant glioma	0.00147	0.002	CcSEcCtD
Capecitabine—Vertigo—Temozolomide—malignant glioma	0.00146	0.00199	CcSEcCtD
Capecitabine—Leukopenia—Temozolomide—malignant glioma	0.00146	0.00198	CcSEcCtD
Capecitabine—Hypertension—Carmustine—malignant glioma	0.00145	0.00198	CcSEcCtD
Capecitabine—Palpitations—Temozolomide—malignant glioma	0.00144	0.00196	CcSEcCtD
Capecitabine—Myalgia—Carmustine—malignant glioma	0.00143	0.00195	CcSEcCtD
Capecitabine—Chest pain—Carmustine—malignant glioma	0.00143	0.00195	CcSEcCtD
Capecitabine—Anxiety—Carmustine—malignant glioma	0.00143	0.00194	CcSEcCtD
Capecitabine—Cough—Temozolomide—malignant glioma	0.00142	0.00193	CcSEcCtD
Capecitabine—Hypertension—Temozolomide—malignant glioma	0.0014	0.00191	CcSEcCtD
Capecitabine—TYMS—Nucleotide metabolism—CAT—malignant glioma	0.00139	0.00663	CbGpPWpGaD
Capecitabine—Confusional state—Carmustine—malignant glioma	0.00139	0.00188	CcSEcCtD
Capecitabine—Arthralgia—Temozolomide—malignant glioma	0.00139	0.00188	CcSEcCtD
Capecitabine—Myalgia—Temozolomide—malignant glioma	0.00139	0.00188	CcSEcCtD
Capecitabine—Anxiety—Temozolomide—malignant glioma	0.00138	0.00188	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00138	0.00187	CcSEcCtD
Capecitabine—Oedema—Carmustine—malignant glioma	0.00137	0.00187	CcSEcCtD
Capecitabine—Discomfort—Temozolomide—malignant glioma	0.00137	0.00186	CcSEcCtD
Capecitabine—Infection—Carmustine—malignant glioma	0.00137	0.00186	CcSEcCtD
Capecitabine—Dry mouth—Temozolomide—malignant glioma	0.00135	0.00184	CcSEcCtD
Capecitabine—Thrombocytopenia—Carmustine—malignant glioma	0.00135	0.00183	CcSEcCtD
Capecitabine—Tachycardia—Carmustine—malignant glioma	0.00134	0.00182	CcSEcCtD
Capecitabine—Confusional state—Temozolomide—malignant glioma	0.00134	0.00182	CcSEcCtD
Capecitabine—Oedema—Temozolomide—malignant glioma	0.00133	0.00181	CcSEcCtD
Capecitabine—Infection—Temozolomide—malignant glioma	0.00132	0.00179	CcSEcCtD
Capecitabine—Anorexia—Carmustine—malignant glioma	0.00131	0.00178	CcSEcCtD
Capecitabine—Nervous system disorder—Temozolomide—malignant glioma	0.0013	0.00177	CcSEcCtD
Capecitabine—Thrombocytopenia—Temozolomide—malignant glioma	0.0013	0.00177	CcSEcCtD
Capecitabine—Skin disorder—Temozolomide—malignant glioma	0.00129	0.00175	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.00129	0.00614	CbGpPWpGaD
Capecitabine—Hypotension—Carmustine—malignant glioma	0.00128	0.00175	CcSEcCtD
Capecitabine—Hyperhidrosis—Temozolomide—malignant glioma	0.00128	0.00175	CcSEcCtD
Capecitabine—Anorexia—Temozolomide—malignant glioma	0.00127	0.00172	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—malignant glioma	0.00126	0.00603	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00125	0.0017	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—GSTP1—malignant glioma	0.00125	0.00595	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—TOP2A—malignant glioma	0.00125	0.00594	CbGpPWpGaD
Capecitabine—Insomnia—Carmustine—malignant glioma	0.00124	0.00169	CcSEcCtD
Capecitabine—Paraesthesia—Carmustine—malignant glioma	0.00123	0.00168	CcSEcCtD
Capecitabine—Dyspnoea—Carmustine—malignant glioma	0.00123	0.00167	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00122	0.00583	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00121	0.00165	CcSEcCtD
Capecitabine—DPYD—Metabolism—COX8A—malignant glioma	0.00121	0.00577	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—malignant glioma	0.0012	0.00574	CbGpPWpGaD
Capecitabine—Insomnia—Temozolomide—malignant glioma	0.0012	0.00163	CcSEcCtD
Capecitabine—Decreased appetite—Carmustine—malignant glioma	0.00119	0.00162	CcSEcCtD
Capecitabine—Paraesthesia—Temozolomide—malignant glioma	0.00119	0.00162	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00119	0.00161	CcSEcCtD
Capecitabine—Dyspnoea—Temozolomide—malignant glioma	0.00118	0.00161	CcSEcCtD
Capecitabine—Constipation—Carmustine—malignant glioma	0.00118	0.0016	CcSEcCtD
Capecitabine—Pain—Carmustine—malignant glioma	0.00118	0.0016	CcSEcCtD
Capecitabine—Dyspepsia—Temozolomide—malignant glioma	0.00117	0.00159	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00116	0.00552	CbGpPWpGaD
Capecitabine—Decreased appetite—Temozolomide—malignant glioma	0.00115	0.00157	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TUBG2—malignant glioma	0.00115	0.00549	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00115	0.00156	CcSEcCtD
Capecitabine—Fatigue—Temozolomide—malignant glioma	0.00114	0.00156	CcSEcCtD
Capecitabine—Constipation—Temozolomide—malignant glioma	0.00114	0.00154	CcSEcCtD
Capecitabine—Pain—Temozolomide—malignant glioma	0.00114	0.00154	CcSEcCtD
Capecitabine—Feeling abnormal—Carmustine—malignant glioma	0.00113	0.00154	CcSEcCtD
Capecitabine—Gastrointestinal pain—Carmustine—malignant glioma	0.00112	0.00153	CcSEcCtD
Capecitabine—Feeling abnormal—Temozolomide—malignant glioma	0.00109	0.00149	CcSEcCtD
Capecitabine—Abdominal pain—Carmustine—malignant glioma	0.00109	0.00148	CcSEcCtD
Capecitabine—Body temperature increased—Carmustine—malignant glioma	0.00109	0.00148	CcSEcCtD
Capecitabine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00109	0.00148	CcSEcCtD
Capecitabine—CDA—Metabolism—COX8A—malignant glioma	0.00108	0.00514	CbGpPWpGaD
Capecitabine—Urticaria—Temozolomide—malignant glioma	0.00105	0.00143	CcSEcCtD
Capecitabine—Abdominal pain—Temozolomide—malignant glioma	0.00105	0.00143	CcSEcCtD
Capecitabine—Body temperature increased—Temozolomide—malignant glioma	0.00105	0.00143	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00105	0.00499	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00103	0.00492	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00103	0.00492	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ASMT—malignant glioma	0.00103	0.00491	CbGpPWpGaD
Capecitabine—Hypersensitivity—Carmustine—malignant glioma	0.00101	0.00138	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—PML—malignant glioma	0.00099	0.00473	CbGpPWpGaD
Capecitabine—Asthenia—Carmustine—malignant glioma	0.000986	0.00134	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—PDGFB—malignant glioma	0.000986	0.0047	CbGpPWpGaD
Capecitabine—Hypersensitivity—Temozolomide—malignant glioma	0.000978	0.00133	CcSEcCtD
Capecitabine—DPYD—Metabolism—BCAN—malignant glioma	0.000967	0.00461	CbGpPWpGaD
Capecitabine—Asthenia—Temozolomide—malignant glioma	0.000953	0.0013	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000943	0.0045	CbGpPWpGaD
Capecitabine—Diarrhoea—Carmustine—malignant glioma	0.00094	0.00128	CcSEcCtD
Capecitabine—Pruritus—Temozolomide—malignant glioma	0.000939	0.00128	CcSEcCtD
Capecitabine—CDA—Metabolism—ASMT—malignant glioma	0.000916	0.00437	CbGpPWpGaD
Capecitabine—Dizziness—Carmustine—malignant glioma	0.000909	0.00124	CcSEcCtD
Capecitabine—Diarrhoea—Temozolomide—malignant glioma	0.000909	0.00124	CcSEcCtD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000906	0.00432	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TOP2A—malignant glioma	0.000906	0.00432	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000894	0.00427	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000892	0.00426	CbGpPWpGaD
Capecitabine—Dizziness—Temozolomide—malignant glioma	0.000878	0.00119	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—malignant glioma	0.000877	0.00418	CbGpPWpGaD
Capecitabine—Vomiting—Carmustine—malignant glioma	0.000874	0.00119	CcSEcCtD
Capecitabine—Rash—Carmustine—malignant glioma	0.000866	0.00118	CcSEcCtD
Capecitabine—Dermatitis—Carmustine—malignant glioma	0.000866	0.00118	CcSEcCtD
Capecitabine—CDA—Metabolism—BCAN—malignant glioma	0.000861	0.00411	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—COX8A—malignant glioma	0.000861	0.00411	CbGpPWpGaD
Capecitabine—Headache—Carmustine—malignant glioma	0.000861	0.00117	CcSEcCtD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000847	0.00404	CbGpPWpGaD
Capecitabine—Vomiting—Temozolomide—malignant glioma	0.000844	0.00115	CcSEcCtD
Capecitabine—Rash—Temozolomide—malignant glioma	0.000837	0.00114	CcSEcCtD
Capecitabine—Dermatitis—Temozolomide—malignant glioma	0.000836	0.00114	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—malignant glioma	0.000835	0.00398	CbGpPWpGaD
Capecitabine—Headache—Temozolomide—malignant glioma	0.000832	0.00113	CcSEcCtD
Capecitabine—Nausea—Carmustine—malignant glioma	0.000816	0.00111	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—MYC—malignant glioma	0.000815	0.00389	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000795	0.00379	CbGpPWpGaD
Capecitabine—Nausea—Temozolomide—malignant glioma	0.000789	0.00107	CcSEcCtD
Capecitabine—DPYD—Metabolism—IDH2—malignant glioma	0.000779	0.00372	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—RTEL1—malignant glioma	0.000767	0.00366	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000735	0.00351	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000734	0.0035	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP2B6—malignant glioma	0.000733	0.0035	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ASMT—malignant glioma	0.000733	0.0035	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NTRK1—malignant glioma	0.000704	0.00336	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000704	0.00336	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000701	0.00335	CbGpPWpGaD
Capecitabine—CDA—Metabolism—IDH2—malignant glioma	0.000694	0.00331	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BCAN—malignant glioma	0.000689	0.00329	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000682	0.00326	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000676	0.00323	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—IDH1—malignant glioma	0.00067	0.0032	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP2B6—malignant glioma	0.000653	0.00312	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SPHK1—malignant glioma	0.000648	0.00309	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP2C18—malignant glioma	0.000635	0.00303	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NCOR1—malignant glioma	0.000616	0.00294	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000614	0.00293	CbGpPWpGaD
Capecitabine—CDA—Metabolism—IDH1—malignant glioma	0.000597	0.00285	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000591	0.00282	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000585	0.00279	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SPHK1—malignant glioma	0.000578	0.00276	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP2C18—malignant glioma	0.000566	0.0027	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—malignant glioma	0.000566	0.0027	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000557	0.00266	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—IDH2—malignant glioma	0.000555	0.00265	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000549	0.00262	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PLK1—malignant glioma	0.000528	0.00252	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000527	0.00252	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—HIST1H3B—malignant glioma	0.000523	0.0025	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2B6—malignant glioma	0.000522	0.00249	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTT1—malignant glioma	0.000514	0.00245	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.00051	0.00244	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000492	0.00235	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000492	0.00235	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS1—malignant glioma	0.000481	0.0023	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—IDH1—malignant glioma	0.000477	0.00228	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000476	0.00227	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000471	0.00225	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SPHK1—malignant glioma	0.000462	0.0022	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTT1—malignant glioma	0.000458	0.00219	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000457	0.00218	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2C18—malignant glioma	0.000453	0.00216	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000452	0.00216	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00045	0.00215	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BCHE—malignant glioma	0.000447	0.00214	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000444	0.00212	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC5A5—malignant glioma	0.000442	0.00211	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—malignant glioma	0.000441	0.00211	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—COX8A—malignant glioma	0.000441	0.0021	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000436	0.00208	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS1—malignant glioma	0.000429	0.00205	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—malignant glioma	0.00041	0.00196	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TOP2A—malignant glioma	0.000408	0.00195	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—H3F3A—malignant glioma	0.000404	0.00193	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000404	0.00193	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000401	0.00191	CbGpPWpGaD
Capecitabine—CDA—Metabolism—BCHE—malignant glioma	0.000399	0.0019	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC5A5—malignant glioma	0.000394	0.00188	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00039	0.00186	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—YWHAE—malignant glioma	0.00039	0.00186	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000385	0.00184	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000381	0.00182	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000375	0.00179	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ASMT—malignant glioma	0.000375	0.00179	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000374	0.00178	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00037	0.00176	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTT1—malignant glioma	0.000366	0.00175	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000362	0.00173	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTP1—malignant glioma	0.000356	0.0017	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BCAN—malignant glioma	0.000352	0.00168	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAT—malignant glioma	0.000346	0.00165	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000346	0.00165	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS1—malignant glioma	0.000343	0.00164	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000336	0.0016	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000327	0.00156	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NCOR1—malignant glioma	0.000327	0.00156	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BCHE—malignant glioma	0.000319	0.00152	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTP1—malignant glioma	0.000317	0.00151	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000316	0.00151	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000315	0.0015	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC5A5—malignant glioma	0.000315	0.0015	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CAT—malignant glioma	0.000309	0.00147	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000304	0.00145	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—malignant glioma	0.000303	0.00144	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000296	0.00141	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BRCA2—malignant glioma	0.000295	0.00141	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2B—malignant glioma	0.000293	0.0014	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NCOR1—malignant glioma	0.000292	0.00139	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000285	0.00136	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH2—malignant glioma	0.000284	0.00136	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000282	0.00135	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2B6—malignant glioma	0.000267	0.00127	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAV1—malignant glioma	0.000267	0.00127	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000262	0.00125	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000256	0.00122	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTP1—malignant glioma	0.000254	0.00121	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BIRC5—malignant glioma	0.000253	0.00121	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAT—malignant glioma	0.000247	0.00118	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—malignant glioma	0.000245	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH1—malignant glioma	0.000244	0.00117	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000244	0.00116	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—malignant glioma	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000242	0.00116	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CAV1—malignant glioma	0.000238	0.00113	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SPHK1—malignant glioma	0.000236	0.00113	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARG—malignant glioma	0.000234	0.00112	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NCOR1—malignant glioma	0.000233	0.00111	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2C18—malignant glioma	0.000232	0.0011	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000222	0.00106	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000221	0.00106	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000219	0.00104	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—malignant glioma	0.000217	0.00103	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000216	0.00103	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000215	0.00103	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CD—malignant glioma	0.000214	0.00102	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARG—malignant glioma	0.000209	0.000997	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000207	0.000986	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—malignant glioma	0.00019	0.000909	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAV1—malignant glioma	0.00019	0.000907	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—malignant glioma	0.000187	0.000894	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000187	0.000893	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CB—malignant glioma	0.000186	0.000888	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—malignant glioma	0.000184	0.00088	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000182	0.000867	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS1—malignant glioma	0.000175	0.000837	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—malignant glioma	0.000173	0.000826	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—malignant glioma	0.000167	0.000799	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—malignant glioma	0.000167	0.000797	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CB—malignant glioma	0.000166	0.000792	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—malignant glioma	0.000164	0.000785	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BCHE—malignant glioma	0.000163	0.000778	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MDM2—malignant glioma	0.000162	0.000775	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SLC5A5—malignant glioma	0.000161	0.000769	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—malignant glioma	0.000161	0.000768	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000158	0.000754	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000153	0.00073	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CD—malignant glioma	0.000152	0.000726	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTEN—malignant glioma	0.000143	0.000684	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CB—malignant glioma	0.000133	0.000633	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—malignant glioma	0.000131	0.000627	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTP1—malignant glioma	0.00013	0.000619	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COX8A—malignant glioma	0.000127	0.000606	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	0.000127	0.000605	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAT—malignant glioma	0.000126	0.000603	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NCOR1—malignant glioma	0.000119	0.000569	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—malignant glioma	0.000115	0.000547	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000114	0.000542	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—malignant glioma	0.000113	0.000542	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—malignant glioma	0.000113	0.000541	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000108	0.000516	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000106	0.000504	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000102	0.000485	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—malignant glioma	0.000101	0.000483	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAV1—malignant glioma	9.72e-05	0.000464	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—malignant glioma	9.31e-05	0.000445	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—malignant glioma	9.27e-05	0.000442	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—malignant glioma	8.86e-05	0.000423	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—malignant glioma	8.55e-05	0.000408	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—malignant glioma	8.26e-05	0.000394	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—IDH2—malignant glioma	8.19e-05	0.000391	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—malignant glioma	8.09e-05	0.000386	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—malignant glioma	7.78e-05	0.000372	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.72e-05	0.000368	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2B6—malignant glioma	7.7e-05	0.000367	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—IDH1—malignant glioma	7.04e-05	0.000336	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SPHK1—malignant glioma	6.81e-05	0.000325	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—malignant glioma	6.79e-05	0.000324	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—malignant glioma	6.72e-05	0.000321	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2C18—malignant glioma	6.67e-05	0.000318	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—malignant glioma	6.61e-05	0.000315	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.29e-05	0.0003	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—malignant glioma	5.86e-05	0.00028	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.73e-05	0.000274	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.53e-05	0.000264	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—malignant glioma	5.4e-05	0.000258	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS1—malignant glioma	5.06e-05	0.000241	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.04e-05	0.00024	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCHE—malignant glioma	4.7e-05	0.000224	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.64e-05	0.000222	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.39e-05	0.00021	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.35e-05	0.000208	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—malignant glioma	4.14e-05	0.000197	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.8e-05	0.000181	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—malignant glioma	3.74e-05	0.000179	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAT—malignant glioma	3.64e-05	0.000174	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOR1—malignant glioma	3.44e-05	0.000164	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—malignant glioma	3.38e-05	0.000161	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAV1—malignant glioma	2.8e-05	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.68e-05	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.55e-05	0.000122	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—malignant glioma	2.46e-05	0.000118	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.24e-05	0.000107	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.96e-05	9.34e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—malignant glioma	1.94e-05	9.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—malignant glioma	1.69e-05	8.07e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.19e-05	5.69e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—malignant glioma	9.74e-06	4.65e-05	CbGpPWpGaD
